Clinical trial capacity development in Rwanda
Professor Eleni Aklillu, from the GH-Pharma research group, is leading a clinical trial capacity strengthening initiative in Rwanda.
The project's initial phase is centered on developing a customized modular clinical trial training program tailored to address Rwanda's needs, using a "train-the-trainers" approach. Subsequent plans include the establishment of diploma and master’s degree programs at the University of Rwanda. By leveraging the PROFORMA project network, which includes Karolinska Institutet, University of Rwanda, Rwanda-Food and Drug Authority, and the Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), a World Bank-supported center of excellence, the initiative aims to bolster clinical trial expertise to support Rwanda’s vaccine biomanufacturing initiative.
The clinical trial training initiative has secured seed funding from SANOFI and the International Vaccine Institute, with the anticipation of potential additional funding from the European Union through Sida.